3174 results for «463»
3174 results
Innovations and novel strategies in CTO PCI
15 May 2024 – From EuroPCR 2024
This session showcases innovative and novel strategies for the percutaneous treatment of chronic total occlusions (CTO) in the coronary arteries. Attendees will learn about techniques such as subintimal rotational ablation with retrograde guidance, external calcium modification, and the use of intravascular lithotripsy to optimize stenting in...
Challenging scenarios in STEMI
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions highlighting challenging scenarios in the management of STEMI (ST-Elevation Myocardial Infarction) patients. Participants will learn about complex cases, such as left main time bomb, coronary anomalies, simultaneous two-vessel acute coronary thrombosis, and mechanical complications. The session includes case presentations...
Undilatable calcified lesion with balloon - LIVE case
15 May 2024 – From EuroPCR 2024
A 66-year-old male with a history of PAD, COPD, diabetes, and an LV function of 44% presented with unstable angina. Coronary angiography revealed a severe and heavily calcified RCA lesion undilatable with a balloon. The patient was referred to a centre specializing in calcified lesion treatment.
Using...
Complex PCI in multivessel disease
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions focused on complex PCI (Percutaneous Coronary Intervention) in patients with multivessel disease. Participants will learn about various challenging cases, including navigating heart failure, three-vessel disease with functional mitral regurgitation, complete revascularization assisted by Impella, and end-stage refractory angina. The...
Post PCI anti-thrombotic strategies
15 May 2024 – From EuroPCR 2024
Percutaneous valvular interventions and cardiogenic shock
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions focused on percutaneous valvular interventions in the context of cardiogenic shock. Learn about complex cases, including severe aortic stenosis with cardiogenic shock, transcatheter treatment of acute heart failure due to surgical prosthetic valve, and acute management of post-AMI papillary...
Clinical adoption of renal denervation: no more excuses
15 May 2024 – From EuroPCR 2024
Intracoronary imaging: PCI guidance
14 May 2024 – From EuroPCR 2024
This session explores the use of various intracoronary imaging techniques to guide complex PCI procedures. It covers cases demonstrating the application of IVUS, OCT, and other imaging modalities in simplifying bifurcation PCI, managing restenotic DES ISR, assessing post-transplant vasculopathy, and optimizing PCI planning and precision. The...
Ostial LAD - Ostial circumflex
15 May 2024 – From EuroPCR 2024
INOCA - MINOCA and nonatherosclerotic coronary artery disease
14 May 2024 – From EuroPCR 2024
This session focuses on the diagnosis and management of INOCA (Ischemia with Non-Obstructive Coronary Arteries), MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries), and other nonatherosclerotic coronary artery diseases. It presents a series of cases highlighting the use of invasive assessment tools like acetylcholine provocation, microvascular analysis,...
Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement
15 May 2024 – From EuroPCR 2024
Bifurcation lesions, challenges, failures and successes
15 May 2024 – From EuroPCR 2024
Management of patient with complex left main stenosis - LIVE case
14 May 2024 – From EuroPCR 2024
A 52-year-old male, with a history of STEMI treated by PPCI on RCA one month ago, presents with angina CCS 2 and severe, calcified stenosis in the LAD, CX, and distal left main. The treatment involved implanting 2 stents in the LAD after Rota preparation, followed...
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
29 Mar 2025
Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.
Author
